Brief: Verona Pharma Expects $400 Mln In Cash & Cash Equivalents As Of Dec 31, 2024
Jan 7 (Reuters) - Verona Pharma PLC I9SAy.F :
* VERONA PHARMA PLC - EXPECTS $400 MILLION IN CASH & CASH
EQUIVALENTS AS OF DEC 31, 2024
* VERONA PHARMA PLC - EXPECTS $36 MILLION IN Q4 NET PRODUCT
SALES
RELATED TO PRODUCT SALES OF OHTUVAYRE
Source text: ID:n0001104659-25-001492
Further company coverage: I9SAy.F
((Reuters.Brief@thomsonreuters.com))
Recent news on Verona Pharma
See all newsBrief: Acquisition Of Verona By Msd Approved By The High Court Of Justice Of England And Wales
Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck
US corporate debt market returns in force after market holiday
Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)
Merck to cut jobs and costs as demand for Gardasil in China remains weak